Mergers & Acquisitions
Apr. 12, 2012
Latham helps South San Francisco company sell to Amgen
The $315 million all cash deal for KAI Pharmaceuticals was reached after a competitive bidding process.
Daily Journal Staff Writer
PALO ALTO - Latham & Watkins LLP helped guide the sale of South San Francisco-based KAI Pharmaceuticals Inc. for $315 million in cash to Amgen Inc. after a bidding process.
"It's another example that a competitive process always helps," Latham partner Alan C. Mendelson said. "There were at least two other major pharma companies that were interested, so the process of negotiatin...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In